21.04.2015 • News

ExxonMobil President Says Bureaucracy Strangling LNG Exports

The US is at risk of losing economic opportunity and the ability to solidify its role as a global leader in energy production if policymakers do not quickly move to approve liquefied natural gas (LNG) exports, Rob Franklin, president of ExxonMobil Gas & Power Marketing Company, said in a speech at the Johns Hopkins School of Advanced International Studies in Washington DC.

With bureaucracy stalling legislation and issuance of export permits, the US role as world's leading energy producer is at stake, Franklin added. In his view, exports of LNG "should be treated no differently from other exports such as agricultural goods, automobiles and computer products.

"LNG exports can provide the spur to further increase America's natural gas production, providing all the attendant benefits that would generate," the executive said.

ExxonMobil is currently engaged in a $10 billion project to convert the LNG regasification terminal at Golden Pass, Texas, into an LNG export terminal. An application to export to non-Free Trade Agreement countries was submitted to federal officials more than two years ago, but no decision has been made.

Permit applications for some two dozen other projects are also in the same state of "bureaucratic limbo."

As global LNG demand is expected to triple between 2010 and 2040, the amount of incremental gas needed to meet global demand by 2025 will be almost double the size of the entire U.S. gas market today," Franklin said, adding that most of the new demand will come from existing and emerging markets in Asia-Pacific and the Middle East.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.